Success rate of clonality assays overall and in subgroups.
收藏数据链接：
官方服务：
资源简介：
Success rate of clonality assays overall and in subgroups.
应用场景：
创建时间：
2019-03-22
相关数据集
3'-TARGET-seq: a novel method for high-sensitivity single-cell mutational analysis and parallel high throughput RNA-sequencing [Figures 5 and 6, Figure S7]. 3'-TARGET-seq: a novel method for high-sensitivity single-cell mutational analysis and parallel high throughput RNA-sequencing [Figures 5 and 6, Figure S7]
We developed 3'-TARGET-seq, a single-cell genotyping and RNA-seq method, which allows accurate detection of multiple mutations within single-cells from genomic and coding DNA in parallel with high thr
NIAID Data Ecosystem30
Table 1_Reduced STAG2 expression in myelodysplastic neoplasms and acute myeloid leukemia myelodysplasia-related: a potential biomarker associated with aneuploidy and disease progression.xlsx
BackgroundMyelodysplastic neoplasms (MDS) are a clonal hematopoietic stem cell disease with an increased risk of progression to acute myeloid leukemia (AML). Cytogenetic abnormalities, mainly aneuploi
NIAID Data Ecosystem10
NGS results and IgH rearrangement analysis in all cases.
NGS results and IgH rearrangement analysis in all cases.
NIAID Data Ecosystem10
List of patients, karyotypes, and fusion genes detected in the RNA target sequencing data of the smear samples.
List of patients, karyotypes, and fusion genes detected in the RNA target sequencing data of the smear samples.
NIAID Data Ecosystem10
Supplementary Material for: Myeloid Neoplasm with PCM1-PDGFRB Transcript Responded to Low-Dose Imatinib: One Case Report with Literature Review
Through an RNA-seq analysis of an adult patient with unclassifiable myelodysplastic/ myeloproliferative neoplasms (MDS/MPN-U), we identified a rare PDGFRB fusion partner gene, PCM1. Conventional chrom
Figshare2022-03-25 更新10
